Hercules Capital Earnings Call Transcripts
Fiscal Year 2026
-
The meeting covered strong 2025 and Q1 2026 financial results, record new commitments, and a new supplemental dividend. All six shareholder proposals passed, including director election and plan amendments. The company highlighted its diversified portfolio and conservative balance sheet.
-
Record Q1 originations and investment income were achieved amid market volatility, with strong credit quality, robust liquidity, and a balanced portfolio across life sciences and technology. Elevated prepayments from M&A are expected in Q2, supporting continued capital redeployment.
Fiscal Year 2025
-
Record 2025 results included all-time highs in originations, fundings, and investment income, with strong credit quality and robust liquidity. The platform is well positioned for 2026, expecting continued growth, disciplined underwriting, and ongoing supplemental shareholder distributions.
-
Record Q3 results included $138.1M total investment income and $88.6M net investment income, with strong origination and portfolio growth. Conservative underwriting and robust liquidity position the platform for continued outperformance and stable distributions.
-
Record Q2 results included $709.1M in gross fundings, $137.5M in investment income, and $88.7M in net investment income, with strong liquidity and improved credit quality. Outlook remains bullish for the second half of 2025, despite a seasonally slow Q3.
-
Q1 saw robust net debt portfolio growth, strong originations, and high liquidity, with total investment income of $119.5 million and net investment income of $77.5 million. Credit quality remained stable, leverage was conservative, and guidance for Q2 anticipates continued strong yields and prepayment activity.
Fiscal Year 2024
-
Record 2024 results included double-digit growth in investment income, net income, and fundings, with strong liquidity and conservative leverage. Outlook for 2025 is optimistic, with plans to increase leverage and capitalize on favorable market conditions.
-
Record Q3 results with $125.2M investment income and $83.2M NII, strong liquidity, and conservative leverage. Despite a slow VC market, pending commitments rose post-Fed rate cut, supporting optimism for Q4 and 2024.
-
Record Q2 fundings and investment income drove strong growth, with assets under management up 14.7% year-over-year. Credit quality remained stable, liquidity was robust, and a new SBIC license added $175M in growth capital. Outlook remains positive despite expected market volatility.